IV-255 is a selective small molecule inhibitor of the BRG1 bromodomain, which heightens DNA damage when administered with Temozolomide and Bleomycin, curtails the invasiveness of GBM cells, and augments both Temozolomide-induced cell death and Temozolomides apoptosis-inducing activity [1].
Molecular Weight:
359.37
Formula:
C19H19F2N3O2
Target:
Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
